Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast cancer incidence in postmenopausal women

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast...

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

Breast cancer cells swallow a 'free lunch' of dietary fat particles from the bloodstream

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive...

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen alone

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen...

SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer

SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in...

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for patients with triple-negative breast cancer with lymph node involvement

SABCS 2019: Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for...

SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to yield clinical benefit in patients with operable HER2-positive early breast cancer

SABCS 2019: Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to...

SABCS 2019: Breast cancer preventive effects of anastrozole persist long after stopping treatment

SABCS 2019: Breast cancer preventive effects of anastrozole persist long after stopping treatment

More from ecancer